Better Buy: Celgene Corporation vs. Gilead Sciences, Inc.
Celgene (NASDAQ: CELG) and Gilead Sciences (NASDAQ: GILD) are two big biotechs facing dramatically different outlooks for the future. Their stock prices reflect that reality. Celgene's share price is up more than 30% over the last 12 months, while Gilead stock is down by a double-digit percentage during the same period.
But the past is the past. Which of these biotech stocks is the better buy for investors now? Here's how Celgene and Gilead Sciences compare.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Stock
€62.35
1.250%
With 12 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 86 € shows a positive potential of 37.93% compared to the current price of 62.35 € for Gilead Sciences Inc.
